SCHEMBL28076211

SCHEMBL28076211

CS(=O)(=O)OCC1(CNC(=O)OCc2ccccc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
HTT P42858 1/20 0.45
ALDH1A1 P00352 2/20 0.44
CTSL P07711 2/20 0.43
CTSB P07858 2/20 0.43
CTSS P25774 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 1/20 0.42
CTSK P43235 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13035566 0.83 LMNA (0.55) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL1395293 0.81 CA12 (0.47) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL16486131 0.81 ALDH1A1 (0.52) LMNACA12CA1CA2CA9
SCHEMBL14476418 0.80 LMNA (0.55) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL14476350 0.80 LMNA (0.55) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL3524616 0.78 LMNA (0.68) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL9281344 0.77 TACR1 (0.42) SMN1; SMN2CA1CA2CA9ALDH1A1
SCHEMBL18131267 0.77 CA12 (0.45) LMNASMN1; SMN2CA12CA1CA2
SCHEMBL30117964 0.77 LMNA (0.46) LMNASMN1; SMN2HTTCTSLCTSB
SCHEMBL31443319 0.77 CA1 (0.45) LMNASMN1; SMN2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106187882-A Prepare method and the synthetic intermediate thereof of compound 克洛维斯肿瘤学意大利公司 2016-12-07 CN disclosed
CN-104193676-B Prepare method and the synthetic intermediate thereof of compound 克洛维斯肿瘤学意大利公司 2016-08-17 CN disclosed